Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 3 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Ocular Therapeutix INC paid sponsored hires in similar roles1 certified filing for “Sr.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 3 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Ocular Therapeutix INC paid sponsored hires in similar roles
- 1 certified filing for “Sr. Manager, Medical and Scientific Publications” (Technical Writers) in MA: $179k–$179k, median $179k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology, ELUTYX™. Ocular Therapeutix has built a robust product pipeline of drug delivery solutions developed to reduce the complexity and burden of the current standard of care and position itself to become a leader in the ophthalmic space.
Outside of the ophthalmic realm and behind the doors of our headquarters in Bedford, MA, we strive to build a strong culture where employees can flourish and achieve their career goals. We encourage out of the box thinking, cross-functional collaboration, and creativity.
Position Summary :
The Medical Affairs and HEOR, National Account Director, will help build and lead a differentiated national account organization at the intersection of Medical Affairs, HEOR, real-world evidence, clinical science, and strategic healthcare collaboration.
This highly visible player-coach role will personally lead relationships with priority payers, health systems, IDNs, academic institutions, and other national healthcare organizations while recruiting and developing a team of National Account Directors. The individual will create integrated account strategies, engage senior healthcare stakeholders, identify evidence gaps and collaboration opportunities, and bring external insights into enterprise strategy.
Reporting directly to the Executive Vice President of Medical Collaborations, this leader will help strengthen the organization’s national account capabilities by building the team, processes, and best practices needed to support effective Medical Affairs and HEOR engagement, in partnership with existing functional and strategic leadership.
Principal Duties and Responsibilities include the following :
• Develop and execute integrated strategies for priority national accounts aligned with medical and market access strategies.
• Build strategic relationships with payer medical directors, health-system leaders, clinicians, health economists, and other senior stakeholders in partnership with and aligned to market access strategies.
• Translate clinical and economic evidence into meaningful value discussions for access stakeholders.
• Engage senior clinical, scientific, health economics, payer, and executive stakeholders in high-value scientific and strategic dialogue
• Identify customer needs, evidence gaps, and opportunities for scientific collaboration and evidence generation.
• Partner with Medical Affairs, HEOR, Medical–Market Access Strategy, Market Access, Clinical Development, Commercial, and other internal functions.
• Capture and communicate external insights to inform evidence planning, scientific communication, and enterprise strategy.
• Build a scalable national account operating model, including account planning, insight collection, engagement standards, and best practices.
• Recruit, coach, and develop a high-performing team of Medical Affairs and HEOR National Account Directors.
• Provide executive leadership with regular updates on account priorities, emerging needs, opportunities, and risks.
Additional Responsibilities:
• Ensure all activities comply with applicable legal, regulatory, industry, and company requirements.
• Maintain appropriate documentation of account plans, engagements, insights, and follow-up activities.
• Represent the organization at payer, Medical Affairs, HEOR, and therapeutic-area meetings and conferences.
• Manage relevant budgets, vendors, and external partners.
• Maintain expertise in applicable disease areas, the treatment landscape, the evidence base, and the evolving healthcare environme
Apply on company site ↗